Could TCR antagonism explain associations between MHC genes and disease?

Hughes, 2002, Natural selection and the diversification of vertebrate immune effectors, Immunol. Rev., 190, 161, 10.1034/j.1600-065X.2002.19012.x Messaoudi, 2002, Direct link between MHC polymorphism, T cell avidity, and diversity in immune defence, Science, 298, 1797, 10.1126/science.1076064 Thorsby, 1997, Invited anniversary review: HLA associated diseases, Hum. Immunol., 53, 1, 10.1016/S0198-8859(97)00024-4 Lopez de Castro, 1998, The pathogenetic role of HLA-B27 in chronic arthritis, Curr. Opin. Immunol., 10, 59, 10.1016/S0952-7915(98)80033-2 McDevitt, 1998, The role of MHC class II molecules in susceptibility and resistance to autoimmunity, Curr. Opin. Immunol., 10, 677, 10.1016/S0952-7915(98)80088-5 Priem, 1988, HLA typing in birdshot chorioretinopathy, Am. J. Ophthalmol., 105, 182, 10.1016/0002-9394(88)90183-3 Cooke, 2001, Genetics of susceptibility to human infectious disease, Nat. Rev. Genet., 2, 967, 10.1038/35103577 O'Hehir, 1991, The specificity and regulation of T-cell responsiveness to allergens, Annu. Rev. Immunol., 9, 67, 10.1146/annurev.iy.09.040191.000435 Romano, 1991, HLA antigens influence resistance to lung carcinoma, Hum. Immunol., 31, 236, 10.1016/0198-8859(91)90093-O Apple, 1994, HLA DR–DQ associations with cervical carcinoma show papillomavirus-type specificity, Nat. Genet., 6, 157, 10.1038/ng0294-157 Goldsmith, 2002, HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis, Clin. Otolaryngol., 27, 61, 10.1046/j.0307-7772.2001.00529.x Hill, 1991, Common west African HLA antigens are associated with protection from severe malaria, Nature, 352, 595, 10.1038/352595a0 Mellors, 1996, Prognosis in HIV-1 infection predicted by the quantity of virus in plasma, Science, 272, 1167, 10.1126/science.272.5265.1167 Klein, 1995, Long-term survivors of HIV-1 infection, Trends Microbiol., 3, 386, 10.1016/S0966-842X(00)88984-2 Kaslow, 1996, Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection, Nat. Med., 2, 405, 10.1038/nm0496-405 Hendel, 1999, New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS, J. Immunol., 162, 6942, 10.4049/jimmunol.162.11.6942 Taurog, 1999, Inflammatory disease in HLA-B27 transgenic rats, Immunol. Rev., 169, 209, 10.1111/j.1600-065X.1999.tb01317.x Khare, 1995, Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: A model of human spondyloarthropaties, J. Exp. Med., 182, 1153, 10.1084/jem.182.4.1153 Szpak, 2001, Spontaneous retinopathy in HLA-A29 transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 98, 2572, 10.1073/pnas.051595998 Arentz-Hansen, 2000, The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase, J. Exp. Med., 191, 603, 10.1084/jem.191.4.603 Zhou, 1998, The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats, J. Exp. Med., 188, 877, 10.1084/jem.188.5.877 Pircher, 1990, Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo, Nature, 346, 629, 10.1038/346629a0 Pewe, 1996, Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease, Immunity, 5, 253, 10.1016/S1074-7613(00)80320-9 Moore, 2002, Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level, Science, 296, 1439, 10.1126/science.1069660 Rickinson, 1997, Human cytotoxic T lymphocyte responses to Epstein–Barr virus infection, Annu. Rev. Immunol., 15, 405, 10.1146/annurev.immunol.15.1.405 Pewe, 1998, Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus, J. Virol., 72, 5912, 10.1128/JVI.72.7.5912-5918.1998 Klenerman, 1998, Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes, Nature, 394, 482, 10.1038/28860 Erickson, 2001, The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes, Immunity, 15, 883, 10.1016/S1074-7613(01)00245-X O'Connor, 2002, Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection, Nat. Med., 8, 493, 10.1038/nm0502-493 Barouch, 2002, Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes, Nature, 415, 335, 10.1038/415335a Scorza Smeraldi, 1986, HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection, Lancet, 2, 1187, 10.1016/S0140-6736(86)92197-5 Gao, 2001, Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS, N. Engl. J. Med., 344, 1668, 10.1056/NEJM200105313442203 Todd, 1987, HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature, 329, 599, 10.1038/329599a0 Moser, 2002, NK cell receptors in antiviral immunity, Curr. Opin. Immunol., 14, 509, 10.1016/S0952-7915(02)00357-6 Spurkland, 1991, HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis, Hum. Immunol., 30, 69, 10.1016/0198-8859(91)90073-I Takacs, 1995, Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice, Eur. J. Immunol., 25, 3134, 10.1002/eji.1830251122 Luhder, 1998, Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities, J. Exp. Med., 187, 379, 10.1084/jem.187.3.379 Sloan-Lankaster, 1996, Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology, Annu. Rev. Immunol., 14, 1, 10.1146/annurev.immunol.14.1.1 De Magistris, 1992, Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor, Cell, 68, 625, 10.1016/0092-8674(92)90139-4 Jameson, 1993, Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells, J. Exp. Med., 177, 1541, 10.1084/jem.177.6.1541 Basu, 1998, In vivo antagonism of a T cell response by an endogenously expressed ligand, Proc. Natl. Acad. Sci. U. S. A., 95, 14332, 10.1073/pnas.95.24.14332 Sette, 1994, Antigen analogs/MHC complexes as specific T cell receptor antagonists, Annu. Rev. Immunol., 12, 413, 10.1146/annurev.iy.12.040194.002213 Jameson, 1995, T cell receptor antagonists and partial agonists, Immunity, 2, 1, 10.1016/1074-7613(95)90074-8 Franco, 1995, Viral mutations, TCR antagonism and escape from the immune response, Curr. Opin. Immunol., 7, 524, 10.1016/0952-7915(95)80098-0 Plebanski, 1999, Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming, Nat. Med., 5, 565, 10.1038/8444 Dillon, 1994, Vβ5+ T cell receptors skew toward OVA+H-2Kb recognition, J. Immunol., 152, 1790, 10.4049/jimmunol.152.4.1790 Anderton, 1999, Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells, Eur. J. Immunol., 29, 1850, 10.1002/(SICI)1521-4141(199906)29:06<1850::AID-IMMU1850>3.0.CO;2-N Hernandez, 1999, Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease, J. Immunol., 163, 3877, 10.4049/jimmunol.163.7.3877 Toda, 2000, Down-regulation of antigen-specific antibody production by TCR antagonist peptides in vivo, Eur. J. Immunol., 30, 403, 10.1002/1521-4141(200002)30:2<403::AID-IMMU403>3.0.CO;2-8 Sloan-Lancaster, 1993, Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells, Nature, 363, 156, 10.1038/363156a0 Sloan-Lancaster, 1994, Th2 cell clonal anergy as a consequence of partial activation, J. Exp. Med., 180, 1195, 10.1084/jem.180.4.1195 Windhagen, 1995, Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand, Immunity, 2, 373, 10.1016/1074-7613(95)90145-0 Nicholson, 1997, A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens, Proc. Natl. Acad. Sci. U. S. A., 94, 9279, 10.1073/pnas.94.17.9279 Reid, 1996, Antagonist HIV-1 Gag peptides induce structural changes in HLA B8, J. Exp. Med., 184, 2279, 10.1084/jem.184.6.2279 Klenerman, 1994, Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants, Nature, 369, 403, 10.1038/369403a0 Meier, 1995, Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants, Science, 270, 1360, 10.1126/science.270.5240.1360 Bertoletti, 1994, Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells, Nature, 369, 407, 10.1038/369407a0 Chang, 1997, Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus, J. Clin. Invest., 100, 2376, 10.1172/JCI119778 Tsai, 1998, Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity, Gastroenterology, 115, 954, 10.1016/S0016-5085(98)70268-9 Frasca, 1999, Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells, J. Immunol., 163, 650, 10.4049/jimmunol.163.2.650 Gilbert, 1998, Association of malaria parasite population structure, HLA, and immunological antagonism, Science, 279, 1173, 10.1126/science.279.5354.1173 Hunziker, 2002, Antagonistic variant virus prevents wild-type virus-induced lethal immunopathology, J. Exp. Med., 196, 1039, 10.1084/jem.20012045 McMichael, 1997, Escape of human immunodeficiency virus from immune control, Annu. Rev. Immunol., 15, 271, 10.1146/annurev.immunol.15.1.271 Stefanova, 2002, Self recognition promotes the foreign antigen sensitivity of naive T lymphocytes, Nature, 420, 429, 10.1038/nature01146 Santori, 2001, Modulation of CD8+ T cell response to antigen by the levels of self MHC class I, J. Immunol., 166, 5416, 10.4049/jimmunol.166.9.5416 Smith, 2001, Sensory adaptation in naive peripheral CD4 T cells, J. Exp. Med., 194, 1253, 10.1084/jem.194.9.1253 Bhandoola, 2002, Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4+ T cells: evidence from a lymphopenic T cell model, Immunity, 17, 425, 10.1016/S1074-7613(02)00417-X Mannie, 1991, A unified model for T cell recognition and thymic selection of the T cell repertoire, J. Theor. Biol., 151, 169, 10.1016/S0022-5193(05)80360-1 Loftus, 1998, Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27–35), Cancer Res., 58, 2433 Ohteki, 1999, Identification of a cross-reactive self ligand in virus-mediated autoimmunity, Eur. J. Immunol., 29, 2886, 10.1002/(SICI)1521-4141(199909)29:09<2886::AID-IMMU2886>3.0.CO;2-A Hudrisier, 2001, Structural and functional identification of major histocompatibility complex class I-restricted self-peptides as naturally occurring molecular mimics of viral antigens. Possible role in CD8+ T cell-mediated, virus-induced autoimmune disease, J. Biol. Chem., 276, 19396, 10.1074/jbc.M008864200 Santori, 2001, Cutting edge: positive selection induced by a self peptide with TCR antagonist activity, J. Immunol., 167, 6092, 10.4049/jimmunol.167.11.6092 Santori, 2002, Rare, structurally homologous self-peptides promote thymocyte positive selection, Immunity, 17, 131, 10.1016/S1074-7613(02)00361-8 Appay, 2000, HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function, J. Exp. Med., 192, 63, 10.1084/jem.192.1.63 Hill, 1995, Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein–Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised, J. Exp. Med., 181, 2221, 10.1084/jem.181.6.2221 Lee, 1999, Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat. Med., 5, 677, 10.1038/9525 Rammensee, 1999, SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, 50, 213, 10.1007/s002510050595 Allen, 1999, The role of HLA-B27 in spondyloarthritis, Immunogenetics, 50, 220, 10.1007/s002510050596 Kappos, 2000, Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group, Nat. Med., 6, 1176, 10.1038/80525 Bielekova, 2000, Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med., 6, 1167, 10.1038/80516 Lin, 2001, Narcolepsy and the HLA region, J. Neuroimmunol., 117, 9, 10.1016/S0165-5728(01)00333-2